Zobrazeno 1 - 10
of 29
pro vyhledávání: '"A. Marije Hoogland"'
Autor:
Chinyere Ibeawuchi, Hartmut Schmidt, Reinhard Voss, Ulf Titze, Mahmoud Abbas, Joerg Neumann, Elke Eltze, Agnes Marije Hoogland, Guido Jenster, Burkhard Brandt, Axel Semjonow
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 2, Pp 3856-3869 (2015)
The multifocal nature of prostate cancer (PCa) creates a challenge to patients’ outcome prediction and their clinical management. An approach that scrutinizes every cancer focus is needed in order to generate a comprehensive evaluation of the disea
Externí odkaz:
https://doaj.org/article/baf4bf7765a94c7b9332d5d71bcd0a0f
Publikováno v:
BMJ Case Reports, 15(3). LIPPINCOTT WILLIAMS & WILKINS
Within the group of gonadal sex cord-stromal tumours, microcystic stromal tumour (MCST) is a rare entity. In the literature, most case series and reviews discussed MCST arising in the ovary, only one case-report concerned a testicular MCST. We presen
Autor:
Axel Semjonow, Burkhard Brandt, Guido Jenster, Agnes Marije Hoogland, Elke Eltze, Joerg Neumann, Mahmoud Abbas, Ulf Titze, Chinyere Ibeawuchi, Reinhard Voss, Hartmut Schmidt
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 6, Pp 11816-11829 (2013)
Prostate cancer is widely observed to be biologically heterogeneous. Its heterogeneity is manifested histologically as multifocal prostate cancer, which is observed more frequently than unifocal prostate cancer. The clinical and prognostic significan
Externí odkaz:
https://doaj.org/article/824bdafa72cb466a87e924057551750e
Autor:
Geert J.L.H. van Leenders, Diederick Duijvesz, Lennard J. M. Dekker, A. Marije Hoogland, Esther I. Verhoef, Giovanny Rodríguez-Blanco, Theo M. Luider, Guido Jenster, Monique J. Roobol
Publikováno v:
The Prostate
Prostate, 79(9), 1032-1042. Wiley-Liss Inc.
Prostate, 79(9), 1032-1042. Wiley-Liss Inc.
textabstractAbstract Background: Proteomic profiling of extracellular vesicles (EVs) from prostate cancer (PCa) and normal prostate cell lines, led to the identification of new candidate PCa markers. These proteins included the nuclear exportin prote
Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
Autor:
Diederick Duijvesz, Kristin E Burnum-Johnson, Marina A Gritsenko, A Marije Hoogland, Mirella S Vredenbregt-van den Berg, Rob Willemsen, Theo Luider, Ljiljana Paša-Tolić, Guido Jenster
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82589 (2013)
BACKGROUND: Current markers for prostate cancer, such as PSA lack specificity. Therefore, novel biomarkers are needed. Unfortunately, the complexity of body fluids often hampers biomarker discovery. An attractive alternative approach is the isolation
Externí odkaz:
https://doaj.org/article/ccea2fec142149aa92685e44666d8aa0
Autor:
Theo M. Luider, Peter A. E. Sillevis Smitt, Guido Jenster, Chris H. Bangma, Geert J.L.H. van Leenders, Esther I. Verhoef, Charlotte F. Kweldam, A. Marije Hoogland, Diederick Duijvesz, Peter C. Burgers, Lona Zeneyedpour, Giovanny Rodríguez-Blanco, Lennard J. M. Dekker
Publikováno v:
Oncotarget
Oncotarget, 9(92), 36444-36456. Impact Journals LLC
Oncotarget, 9(92), 36444-36456. Impact Journals LLC
Although many patients are cured from prostate cancer (PCa) by surgery only, there are still patients who will experience rising prostate-specific antigen (PSA) levels after surgery, a condition known as biochemical recurrence (BCR). Novel protein pr
Autor:
Bernard Têtu, Jure Murgic, Anuradha Gopalan, Yves Fradet, Paul C. Boutros, Robert G. Bristow, Julie Livingstone, Melvin L.K. Chua, Louis Lacombe, Hélène Hovington, Alain Bergeron, Michèle Orain, Valérie Picard, Emilie Lalonde, Alice Meng, Osman Mahamud, Alan Dal Pra, Victor E. Reuter, Charlotte F. Kweldam, Neil Fleshner, Vinayak Bhandari, Melania Pintilie, Winnie Lo, Esther I. Verhoef, Agnes Marije Hoogland, Alejandro Berlin, Michael Fraser, Theodorus H. van der Kwast, Geert J.L.H. van Leenders, Junyan Zhang
Publikováno v:
European Urology, 72(5), 665-674. Elsevier
BACKGROUND Intraductal carcinoma (IDC) and cribriform architecture (CA) represent unfavorable subpathologies in localized prostate cancer. We recently showed that IDC shares a clonal ancestry with the adjacent glandular adenocarcinoma. OBJECTIVE We i
Autor:
Han J. Bonenkamp, Eva M. Noorda, Marije Hoogland, Anne Brecht Francken, Brian Vendel, Marieke Bolster, Anouk Huberts
Publikováno v:
European Journal of Surgical Oncology. 47:e59
Autor:
Marije Zwakman, Engelbertus Gerardus Johannes Maria Pierik, Judith Eleonora Katharina Regina Hentzen, Anne Brecht Francken, Agnes Marije Hoogland, José van der Starre-Gaal
Publikováno v:
Journal of Surgery. 9:233
Soft-tissue tumors range from benign to malignant tumors. Although these tumors are frequently unsuspected during surgical excision, additional pathology examination is usually performed in the absence of national guidelines in combination with the f
Autor:
Geert J.L.H. van Leenders, Maria J. De Herdt, Hein F.B.M. Sleddens, Leendert H. J. Looijenga, Esther I. Verhoef, A. Marije Hoogland, Kimberley Kolijn, Berdine van der Steen
Publikováno v:
Oncotarget
Oncotarget, 7(21), 31029-31036. Impact Journals LLC
Oncotarget, 7(21), 31029-31036. Impact Journals LLC
Tyrosine-kinase inhibitors of the hepatocyte growth factor receptor MET are under investigation for the treatment of hormone-refractory prostate cancer (HRPC) metastasis. Analysis of MET protein expression and genetic alterations might contribute to